Eculizumab in paroxysmal nocturnal hemoglobinuria

被引：0

作者：

Socie, Gerard ^{[1
]}

Varoqueaux, Nathalie ^{[2
]}

de Latour, Regis Peffault ^{[1
]}

机构：

[1] Hop St Louis, INSERM, AP HP, Serv Hematol Greffe,U728, F-75010 Paris, France

[2] Alexion Pharma France, Direct Affaires Med, F-75008 Paris, France

来源：

M S-MEDECINE SCIENCES | 2009年 / 25卷 / 12期

关键词：

COMPLEMENT INHIBITOR ECULIZUMAB; PIG-A GENE; MICROPARTICLES; HEMOLYSIS; DISEASE;

D O I：

10.1051/medsci/200925121126

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

Eculizumab in paroxysmal nocturnal hemoglobinuria Paroxysmal nocturnal hemoglobinuria is a rare acquired clonal of the hematopoietic stem cell due to acquired mutation of the PIG-A gene. This results in the lack of two GPI-anchored membrane proteins involved in the inhibition of complement attack, thus explaining red cells hemolysis. The development of an anti-C5 monoclonal antibody (eculizumab) had profoundly modified the treatment of the the hemolytic form of the disease.

引用

页码：1126 / 1129

页数：4

共 18 条

[11] THE CLONING OF PIG-A, A COMPONENT IN THE EARLY STEP OF GPI-ANCHOR BIOSYNTHESIS [J].

MIYATA, T ;

TAKEDA, J ;

IIDA, Y ;

YAMADA, N ;

INOUE, N ;

TAKAHASHI, M ;

MAEDA, K ;

KITANI, T ;

KINOSHITA, T .

SCIENCE, 1993, 259 (5099) :1318-1321

[12] MUTATIONS IN THE PIG-A GENE CAUSING PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA ARE MAINLY OF THE FRAMESHIFT TYPE [J].

NAFA, K ;

MASON, PJ ;

HILLMEN, P ;

LUZZATTO, L ;

BESSLER, M .

BLOOD, 1995, 86 (12) :4650-4655

[13] Diagnosis and management of paroxysmal nocturnal hemoglobinuria [J].

Parker, C ;

Omine, M ;

Richards, S ;

Nishimura, J ;

Bessler, M ;

Ware, R ;

Hillmen, P ;

Luzzatto, L ;

Young, N ;

Kinoshita, T ;

Rosse, W ;

Socié, G .

BLOOD, 2005, 106 (12) :3699-3709

[14] THE MOLECULAR-BASIS OF PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA [J].

ROSSE, WF ;

WARE, RE .

BLOOD, 1995, 86 (09) :3277-3286

[15] The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin - A novel mechanism of human disease [J].

Rother, RP ;

Bell, L ;

Hillmen, P ;

Gladwin, MT .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (13) :1653-1662

[16] Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria [J].

Rother, Russell P. ;

Rollins, Scott A. ;

Mojcik, Christopher F. ;

Brodsky, Robert A. ;

Bell, Leonard .

NATURE BIOTECHNOLOGY, 2007, 25 (11) :1256-1264

[17]

Rotoli B, 1989, Baillieres Clin Haematol, V2, P113, DOI 10.1016/S0950-3536(89)80010-1

[18] DEFICIENCY OF THE GPI ANCHOR CAUSED BY A SOMATIC MUTATION OF THE PIG-A GENE IN PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA [J].

TAKEDA, J ;

MIYATA, T ;

KAWAGOE, K ;

IIDA, Y ;

ENDO, Y ;

FUJITA, T ;

TAKAHASHI, M ;

KITANI, T ;

KINOSHITA, T .

CELL, 1993, 73 (04) :703-711

← 1 2 →